Literature DB >> 70787

Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

S Nagasawa, R M Stroud.   

Abstract

The activation of complement component C2 by C1s is a major reaction step leading to the assembly of two related macromolecular enzymes in the classical complement pathway C3 convertase and C5 convertase. The present studies clearly document the smaller fragment, C2b, that results when human C2 reacts with C1s. We have identified and characterized C2b (34,000 daltons) as a single protein on disc electrophoresis and immunoelectrophoresis. C2a (73,000 daltons), the larger fragment from this reaction, has a more acidic nature and C2b is more basic. These fragments can also be detected by their different antigenic determinants. When the C2-C4b complex is activated in the fluid phase by C1s and allowed to decay, it dissociates into C2a and the C2b-C4b complex. Furthermore, when C2 is bound to C4b-Sepharose and then reacted with C1s, only the C2a fragment is released from the solid phase C2-C4b-Sepharose into the fluid phase, and the C2b fragment remains noncovalently bound to C4b-Sepharose. These results suggest that the C2b portion of C2 contains a stable binding site for C4b and, after the decay release of C2a from this C3 convertase, the C2b fragment remains bound. Thus, the decay release of C2a may represent a temperature-dependent dissociation from C2b.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70787      PMCID: PMC431380          DOI: 10.1073/pnas.74.7.2998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  The serine protease nature of the C3 and C5 convertases of the classical and alternative complement pathways.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

3.  The NH-2-terminal sequences of a subunit of the first component of human complement, C1s, and its activated form, C1s.

Authors:  K Takahashi; S Nagasawa; J Koyama
Journal:  FEBS Lett       Date:  1975-02-15       Impact factor: 4.124

4.  Enzymatic activity of the second component of complement.

Authors:  N R Cooper
Journal:  Biochemistry       Date:  1975-09-23       Impact factor: 3.162

5.  On the cleavage of C'2 by C'la: immunological and physical comparisons of C'2ad and C'2a-i.

Authors:  J A Miller; M M Mayer
Journal:  Proc Soc Exp Biol Med       Date:  1968-10

6.  Measurement of protein concentration with interferences optics.

Authors:  J Babul; E Stellwagen
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

7.  Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.

Authors:  M B Goldlust; H S Shin; C H Hammer; M M Mayer
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

8.  C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a.

Authors:  R M Stroud; M M Mayer; J A Miller; A T McKenzie
Journal:  Immunochemistry       Date:  1966-05

9.  Reversible adsorption of C'2 by EAC'4: role of Mg2+, enumeration of competent SAC'4, two-step nature of C'2a fixation and estimation of its efficiency.

Authors:  G Sitomer; R M Stroud; M M Mayer
Journal:  Immunochemistry       Date:  1966-01

10.  The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  36 in total

1.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

2.  Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis.

Authors:  S J Perkins; L P Chung; K B Reid
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

3.  Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A van Es
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A Vanes; A Cats
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

7.  Sequence determination of the thiolester site of the fourth component of human complement.

Authors:  R A Harrison; M L Thomas; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.

Authors:  M A Kerr; C Parkes
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

10.  The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.

Authors:  C Parkes; J Gagnon; M A Kerr
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.